# Anuh Pharma Ltd (ANUHPHR)
> Exchange: NSE | Sector: Pharma | ISIN: INE489G01022

## Price
Current Price: ₹75.58
Day Change: -0.77%
52W High: ₹114.9
52W Low: ₹67
Market Cap: ₹799 Cr

## Valuation
P/E: 19.13
P/B: 2.44
EPS: ₹4.17
Book Value: ₹32.64
Dividend Yield: 0%

## Returns
1Y Return: -8.51%

## Profitability
ROE: 0%
ROCE: 28.3%
Debt/Equity: 0
Revenue Growth: 23.6%
Profit Growth: 30.1%
EBITDA Margin: 7.51%
Operating Margin: 7%

## About
Anuh Pharma Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Anuh Pharma Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Quarterly Report: Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2026, Recommendation Of Final Dividend, If Any, And Consideration Of AGM Notice For The Financial Year 2025-26.
- Announcement: Announcement Under Regulation 30 (LODR) - Updates
- BSE Filing: Announcement Under Regulation 30 (LODR) - Updates

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.754Z
Price History Updated: 2026-05-25T05:24:19.966Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:24:19.966Z
Quant Updated: 2026-05-25T05:24:19.966Z
Sentiment Updated: 2026-05-25T05:24:19.966Z
Financials Status: current
Financials Updated: 2026-05-19T12:31:41.273Z
Financials Last Attempt: 2026-05-19T12:31:41.273Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹661.51 Cr
Operating Profit: ₹56.84 Cr (OPM 8.59%)
Net Profit: ₹47.35 Cr
Tax: ₹13.65 Cr

## Annual P&L History
FY25: Rev ₹661.51Cr | PAT ₹47.35Cr | OPM 8.59%
FY24: Rev ₹647Cr | PAT ₹60.06Cr | OPM 10.46%
FY23: Rev ₹527.49Cr | PAT ₹36.18Cr | OPM 8.43%

## Balance Sheet (FY25)
Total Assets: ₹506.63 Cr
Total Liabilities: ₹180.6 Cr
Borrowings: ₹10.89 Cr
Cash: ₹19.56 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Ritesh Bipin Shah MBA, Joint MD & Executive Director
- Vivek Bipin Shah M.Sc, Joint MD & Executive Director
- Bipin Nemchand Shah, Non-Executive Director
- Darshan Dhirajlal Rampariya, Chief Financial Officer
- Manan Jayesh Vadhan, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/anuhphr
Disclaimer: For research and education only. Not investment advice.